Cargando…
Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease
OBJECTIVE: This study was mainly conducted to explore the expression changes of GSDMD and conventional markers (including T‐Tau, Tau181p, and Aβ(1–42)) in the cerebrospinal fluid among patients with Alzheimer's disease (AD) and vascular dementia (VD), followed by determination of role of GSDMD...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035446/ https://www.ncbi.nlm.nih.gov/pubmed/33587329 http://dx.doi.org/10.1002/brb3.2063 |